RDT Products

Rare Disease Therapeutics, Inc., (RDT) is currently developing Orphan products, acquiring Orphan products through strategic alliances, and distributing Orphan products through third-party contractors with facilities and logistics expertise to provide distribution throughout the Americas. RDT works closely with the FDA’s Office of Orphan Product Development, National Organization for Rare Disorders (NORD), the National Institutes of Health, large international pharmaceutical companies, and patient advocacy groups to identify the unmet needs of patients with rare diseases and potential products to meet these needs.

PRODUCT NAMETherapeutic Area
ANASCORP [Centruroides (Scorpion) Immune F(ab’)2 (Equine)] InjectionAntivenoms
ANASCORP [Centruroides (Scorpion) Immune F(ab’)2 (Equine)] InjectionAntivenoms
PURIXAN® (mercaptopurine)Oncology

To report a suspected adverse reaction or to order any of our products, please call 844-472-7389.

America's First
Exclusively Orphan
Drug Company